Comparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth maintained, in contrast to growth suppression commonly seen with standard of care corticosteroids ...
Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...
The uncertainty inherent to quantum mechanics has long left physicists wondering whether the observations we make on the ...
A research team led by the Institute for Bioengineering of Catalonia (IBEC) and collaborating with the Biomedical Research ...
Mumbai: The primary root cause for the disruption which halted trading for four hours on Multi Commodity Exchange (MCX) this ...
Greene Tweed examines failure behavior, identifying key factors for improvement and demonstrating sufficient design for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback